2,3-di-O-methyl-alpha-D-glucopyranose

Details

Top
Internal ID a408311f-3e31-4639-aa15-d38ec7dfccd0
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Monosaccharides
IUPAC Name (2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4-dimethoxyoxane-2,5-diol
SMILES (Canonical) COC1C(C(OC(C1OC)O)CO)O
SMILES (Isomeric) CO[C@H]1[C@@H]([C@H](O[C@@H]([C@@H]1OC)O)CO)O
InChI InChI=1S/C8H16O6/c1-12-6-5(10)4(3-9)14-8(11)7(6)13-2/h4-11H,3H2,1-2H3/t4-,5-,6+,7-,8+/m1/s1
InChI Key SQYIWHJCOMWKNU-CBQIKETKSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C8H16O6
Molecular Weight 208.21 g/mol
Exact Mass 208.09468823 g/mol
Topological Polar Surface Area (TPSA) 88.40 Ų
XlogP -1.50
Atomic LogP (AlogP) -1.91
H-Bond Acceptor 6
H-Bond Donor 3
Rotatable Bonds 3

Synonyms

Top
2,3-di-O-methyl-alpha-D-glucopyranose

2D Structure

Top
2D Structure of 2,3-di-O-methyl-alpha-D-glucopyranose

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8733 87.33%
Caco-2 - 0.8486 84.86%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.5571 55.71%
Subcellular localzation Mitochondria 0.7203 72.03%
OATP2B1 inhibitior - 0.8571 85.71%
OATP1B1 inhibitior + 0.8718 87.18%
OATP1B3 inhibitior + 0.9538 95.38%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9690 96.90%
P-glycoprotein inhibitior - 0.9430 94.30%
P-glycoprotein substrate - 0.9737 97.37%
CYP3A4 substrate - 0.5908 59.08%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8285 82.85%
CYP3A4 inhibition - 0.9409 94.09%
CYP2C9 inhibition - 0.9464 94.64%
CYP2C19 inhibition - 0.9191 91.91%
CYP2D6 inhibition - 0.9347 93.47%
CYP1A2 inhibition - 0.9683 96.83%
CYP2C8 inhibition - 0.9566 95.66%
CYP inhibitory promiscuity - 0.8910 89.10%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.7372 73.72%
Eye corrosion - 0.9750 97.50%
Eye irritation - 0.9138 91.38%
Skin irritation - 0.8732 87.32%
Skin corrosion - 0.9710 97.10%
Ames mutagenesis - 0.8100 81.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4491 44.91%
Micronuclear - 0.7541 75.41%
Hepatotoxicity - 0.7361 73.61%
skin sensitisation - 0.9320 93.20%
Respiratory toxicity - 0.8778 87.78%
Reproductive toxicity - 0.5667 56.67%
Mitochondrial toxicity - 0.9125 91.25%
Nephrotoxicity + 0.5119 51.19%
Acute Oral Toxicity (c) III 0.5935 59.35%
Estrogen receptor binding - 0.8719 87.19%
Androgen receptor binding - 0.7244 72.44%
Thyroid receptor binding - 0.5303 53.03%
Glucocorticoid receptor binding - 0.8062 80.62%
Aromatase binding - 0.7574 75.74%
PPAR gamma - 0.7778 77.78%
Honey bee toxicity - 0.8403 84.03%
Biodegradation - 0.5250 52.50%
Crustacea aquatic toxicity - 0.7103 71.03%
Fish aquatic toxicity - 0.9500 95.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.16% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 88.83% 91.11%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 85.25% 86.92%
CHEMBL226 P30542 Adenosine A1 receptor 84.58% 95.93%
CHEMBL3060 Q9Y345 Glycine transporter 2 81.00% 99.17%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.91% 97.25%

Cross-Links

Top
PubChem 14211992
NPASS NPC245418